{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:07:00Z","timestamp":1793650020607,"version":"4.5.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Science and Technology Council"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10495-026-02380-5","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T17:29:09Z","timestamp":1781803749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Heteronemin suppresses chemoresistant oral squamous cell carcinoma cells through ROS-mediated apoptosis and cuproptosis-associated mitochondrial stress"],"prefix":"10.1007","volume":"31","author":[{"given":"Chiung-Wei","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan-Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Feng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Hsuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Ju","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Min","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Ying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue-Liang","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Ya","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien Hsing","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"2380_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.218015","volume":"634","author":"N Maharajan","year":"2025","unstructured":"Maharajan N, Benyamien-Roufaeil DS, Brown RA, Portney BA, Banerjee A, Zalzman M (2025) Cancer stem cell mechanisms and targeted therapeutic strategies in head and neck squamous cell carcinoma. Cancer Lett 634:218015","journal-title":"Cancer Lett"},{"key":"2380_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103819","volume":"86","author":"Y Nakayama","year":"2025","unstructured":"Nakayama Y, Taguchi K, Wakamori S et al (2025) Cisplatin-induced genetic alterations in KEAP1 promote therapeutic resistance in head and neck squamous cell carcinoma. Redox Biol 86:103819","journal-title":"Redox Biol"},{"key":"2380_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2174\/0113892029278082240118053857","volume":"25","author":"A Xing","year":"2024","unstructured":"Xing A, Lv D, Wu C et al (2024) Tertiary lymphoid structures gene signature predicts prognosis and immune infiltration analysis in head and neck squamous cell carcinoma. Curr Genomics 25:88\u2013104","journal-title":"Curr Genomics"},{"key":"2380_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2174\/0113892029284920240212091903","volume":"25","author":"N Baqai","year":"2024","unstructured":"Baqai N, Amin R, Fatima T, Ahmed Z, Faiz N (2024) Expression profiling of EMT transcriptional regulators ZEB1 and ZEB2 in different histopathological grades of oral squamous cell carcinoma patients. Curr Genomics 25:140\u2013151","journal-title":"Curr Genomics"},{"key":"2380_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2174\/0115665232305905240521081553","volume":"25","author":"M Easwaran","year":"2025","unstructured":"Easwaran M, Madasamy S, Venkidasamy B (2025) Theranostic potential of bacteriophages against oral squamous cell carcinoma. Curr Gene Ther 25:89\u201391","journal-title":"Curr Gene Ther"},{"key":"2380_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41389-025-00563-4","volume":"14","author":"HC Chuang","year":"2025","unstructured":"Chuang HC, Tsai MH, Chuang JH, Hong YT, Chien CY, Chou MH (2025) ONC201 enhances the cytotoxic effect of cisplatin through ATF3\/ATF4\/CHOP in head and neck squamous cell carcinoma cells. Oncogenesis 14:20","journal-title":"Oncogenesis"},{"key":"2380_CR7","doi-asserted-by":"publisher","first-page":"482","DOI":"10.2174\/1568009623666230206143216","volume":"23","author":"T Chen","year":"2023","unstructured":"Chen T, Yang F, Dai X et al (2023) VE-822 enhanced cisplatin chemotherapy effects on head and neck squamous cell carcinoma drug-resistant cells. Curr Cancer Drug Targets 23:482\u2013495","journal-title":"Curr Cancer Drug Targets"},{"key":"2380_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2023.105637","volume":"147","author":"H Shanchun","year":"2023","unstructured":"Shanchun H, You P, Sujuan N et al (2023) Integrative analyses of biomarkers and pathways for metformin reversing cisplatin resistance in head and neck squamous cell carcinoma cells. Arch Oral Biol 147:105637","journal-title":"Arch Oral Biol"},{"key":"2380_CR9","doi-asserted-by":"publisher","first-page":"1497668","DOI":"10.3389\/fphar.2024.1497668","volume":"15","author":"M Ahmad","year":"2024","unstructured":"Ahmad M, Tahir M, Hong Z et al (2024) Plant and marine-derived natural products: sustainable pathways for future drug discovery and therapeutic development. Front Pharmacol 15:1497668","journal-title":"Front Pharmacol"},{"key":"2380_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/md22050191","volume":"22","author":"F Lv","year":"2024","unstructured":"Lv F, Zeng Y (2024) Novel bioactive natural products from marine-derived penicillium fungi: a review (2021\u20132023). Mar Drugs 22:191","journal-title":"Mar Drugs"},{"key":"2380_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3892\/or.2025.8865","volume":"53","author":"YSH Yang","year":"2025","unstructured":"Yang YSH, Tsai CC, Yang YN et al (2025) Heteronemin suppresses EGF-induced proliferation through the PI3K\/PD-L1 signaling pathways in cholangiocarcinoma. Oncol Rep 53:32","journal-title":"Oncol Rep"},{"key":"2380_CR12","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s00210-023-02736-7","volume":"397","author":"G Kaftan","year":"2024","unstructured":"Kaftan G, Erdogan MA, El-Shazly M et al (2024) Heteronemin promotes iron-dependent cell death in pancreatic cancer. Naunyn Schmiedebergs Arch Pharmacol 397:1865\u20131874","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2380_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2025.111879","volume":"424","author":"Y Wang","year":"2026","unstructured":"Wang Y, Zhou M, Lan J, Hu T, Wang T, Zuo C (2026) Copper homeostasis and its dysregulation in diseases: a focus on cuproptosis. Chem Biol Interact 424:111879","journal-title":"Chem Biol Interact"},{"key":"2380_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/bfgp\/elaf023","volume":"25","author":"J Luo","year":"2026","unstructured":"Luo J, Su M, Li X et al (2026) Effect of EGR1\/LIPT1 regulatory axis on cuproptosis in chromophobe renal cell carcinoma. Brief Funct Genom 25:elaf023","journal-title":"Brief Funct Genom"},{"key":"2380_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3892\/ijmm.2026.5727","volume":"57","author":"L Zhang","year":"2026","unstructured":"Zhang L, Cheng Y, Tang L, Zhu J, Tuo B (2026) Role of cuproptosis in digestive system tumors (review). Int J Mol Med 57:56","journal-title":"Int J Mol Med"},{"key":"2380_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s13402-025-01138-6","volume":"49","author":"X Zhou","year":"2026","unstructured":"Zhou X, Peng S (2026) The cross-talk and interplay between ferroptosis and cuproptosis in tumor and therapeutics. Cell Oncol (Dordr) 49:19","journal-title":"Cell Oncol (Dordr)"},{"key":"2380_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155790","volume":"266","author":"D Wang","year":"2025","unstructured":"Wang D, Guan H (2025) Cuproptosis: a new mechanism for anti-tumour therapy. Pathol Res Pract 266:155790","journal-title":"Pathol Res Pract"},{"key":"2380_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154655","volume":"111","author":"CL Lin","year":"2023","unstructured":"Lin CL, Yu CI, Lee TH et al (2023) Plumbagin induces the apoptosis of drug-resistant oral cancer in vitro and in vivo through ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction. Phytomedicine 111:154655","journal-title":"Phytomedicine"},{"key":"2380_CR19","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1101\/pdb.prot087205","volume":"2016","author":"LC Crowley","year":"2016","unstructured":"Crowley LC, Marfell BJ, Waterhouse NJ (2016) Analyzing cell death by nuclear staining with hoechst 33342. Cold Spring Harb Protoc 2016:778","journal-title":"Cold Spring Harb Protoc"},{"key":"2380_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13045-017-0436-9","volume":"10","author":"GJ Yoshida","year":"2017","unstructured":"Yoshida GJ (2017) Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment. J Hematol Oncol 10:67","journal-title":"J Hematol Oncol"},{"key":"2380_CR21","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B et al (2022) Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375:1254\u20131261","journal-title":"Science"},{"key":"2380_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105046","volume":"299","author":"MB Dreishpoon","year":"2023","unstructured":"Dreishpoon MB, Bick NR, Petrova B et al (2023) FDX1 regulates cellular protein lipoylation through direct binding to LIAS. J Biol Chem 299:105046","journal-title":"J Biol Chem"},{"key":"2380_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2025.109596","volume":"152\u2013153","author":"MR Lewis","year":"2026","unstructured":"Lewis MR, Chambers CG, Heidari-Kharaji M et al (2026) PET imaging of [(64)Cu]copper(II) chloride and tetrathiomolybdate administration in animal models of triple-negative breast cancer. Nucl Med Biol 152\u2013153:109596","journal-title":"Nucl Med Biol"},{"key":"2380_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14081002","volume":"14","author":"N Brandl","year":"2025","unstructured":"Brandl N, Seitz R, Sendtner N, Muller M, Gulow K (2025) Living on the edge: ROS homeostasis in cancer cells and its potential as a therapeutic target. Antioxidants (Basel) 14:1002","journal-title":"Antioxidants (Basel)"},{"key":"2380_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-026-02583-x","volume":"11","author":"S Akter","year":"2026","unstructured":"Akter S, Madhuvilakku R, Kar AK et al (2026) Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications. Signal Transduct Target Ther 11:111","journal-title":"Signal Transduct Target Ther"},{"key":"2380_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.70107","volume":"86","author":"R Tiwari","year":"2025","unstructured":"Tiwari R, Mondal Y, Bharadwaj K, Mahajan M, Mondal S, Sarkar A (2025) Reactive oxygen species (ROS) and their profound influence on regulating diverse aspects of cancer: a concise review. Drug Dev Res 86:e70107","journal-title":"Drug Dev Res"},{"key":"2380_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02553-2","volume":"11","author":"J Li","year":"2025","unstructured":"Li J, Li N, Wang H et al (2025) Cuproptosis and cuproptosis-related cell death and genes: mechanistic links to spermatogenic cell death. Cell Death Discov 11:274","journal-title":"Cell Death Discov"},{"key":"2380_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70947","volume":"14","author":"I Attique","year":"2025","unstructured":"Attique I, Haider Z, Khan M et al (2025) Reactive oxygen species: from tumorigenesis to therapeutic strategies in cancer. Cancer Med 14:e70947","journal-title":"Cancer Med"},{"key":"2380_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.71002","volume":"15","author":"L Zeng","year":"2026","unstructured":"Zeng L, Ding N, Chen Z et al (2026) Redox dual-responsive drug delivery system with cascade of reactive oxygen species self-generation for enhanced cancer chemotherapy. Adv Healthc Mater 15:e71002","journal-title":"Adv Healthc Mater"},{"key":"2380_CR30","doi-asserted-by":"publisher","first-page":"51783","DOI":"10.1021\/acsami.4c11112","volume":"16","author":"Z Zhao","year":"2024","unstructured":"Zhao Z, Zhang Y, Fan Y et al (2024) Mitochondrial sulfenated-protein-targeted covalent immobilization boosting efficient copper(II) depletion for enhanced cancer treatment. ACS Appl Mater Interfaces 16:51783\u201351797","journal-title":"ACS Appl Mater Interfaces"},{"key":"2380_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202304522","volume":"13","author":"J Deng","year":"2024","unstructured":"Deng J, Zhuang H, Shao S et al (2024) Mitochondrial-targeted copper delivery for cuproptosis-based synergistic cancer therapy. Adv Healthc Mater 13:e2304522","journal-title":"Adv Healthc Mater"},{"key":"2380_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202415176","volume":"12","author":"M Andreana","year":"2025","unstructured":"Andreana M, Sentosa R, Sturtzel C et al (2025) Multimodal investigation of angiogenesis and its prevention by small compounds in a zebrafish cancer model. Adv Sci (Weinh) 12:e15176","journal-title":"Adv Sci (Weinh)"},{"key":"2380_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70942","volume":"14","author":"Y Sugino","year":"2025","unstructured":"Sugino Y, Bao X, Kageyama T et al (2025) Narrative review of patient cancer tissue-derived zebrafish xenograft models for evaluating drug sensitivity as an avatar model for clinical application. Cancer Med 14:e70942","journal-title":"Cancer Med"},{"key":"2380_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.629888","volume":"8","author":"ZJ Law","year":"2021","unstructured":"Law ZJ, Khoo XH, Lim PT et al (2021) Extracellular vesicle-mediated chemoresistance in oral squamous cell carcinoma. Front Mol Biosci 8:629888","journal-title":"Front Mol Biosci"},{"key":"2380_CR35","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/odi.15075","volume":"31","author":"T Zhou","year":"2025","unstructured":"Zhou T, Zhang X, Yang D et al (2025) Metformin overcomes chemoresistance by regulating stemness via KLF4 in oral squamous cell carcinoma. Oral Dis 31:468\u2013481","journal-title":"Oral Dis"},{"key":"2380_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2022.112850","volume":"161","author":"CC Chung","year":"2022","unstructured":"Chung CC, Huang TY, Chu HR et al (2022) Heteronemin and tetrac derivatives suppress non-small cell lung cancer growth via ERK1\/2 inhibition. Food Chem Toxicol 161:112850","journal-title":"Food Chem Toxicol"},{"key":"2380_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/md18070348","author":"CH Huang","year":"2020","unstructured":"Huang CH, Huang TY, Chang WJ et al (2020) Combined treatment of heteronemin and tetrac induces antiproliferation in oral cancer cells. Mar Drugs. https:\/\/doi.org\/10.3390\/md18070348","journal-title":"Mar Drugs"},{"key":"2380_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/md20080482","author":"S Unson","year":"2022","unstructured":"Unson S, Chang TC, Yang YN et al (2022) Heteronemin and tetrac induce anti-proliferation by blocking EGFR-mediated signaling in colorectal cancer cells. Mar Drugs. https:\/\/doi.org\/10.3390\/md20080482","journal-title":"Mar Drugs"},{"key":"2380_CR39","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/pros.23230","volume":"76","author":"JC Wu","year":"2016","unstructured":"Wu JC, Wang CT, Hung HC et al (2016) Heteronemin is a novel c-Met\/STAT3 inhibitor against advanced prostate cancer cells. Prostate 76:1469\u20131483","journal-title":"Prostate"},{"key":"2380_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.688607","volume":"9","author":"YSH Yang","year":"2021","unstructured":"Yang YSH, Li ZL, Huang TY et al (2021) Effect of estrogen on heteronemin-induced anti-proliferative effect in breast cancer cells with different estrogen receptor status. Front Cell Dev Biol 9:688607","journal-title":"Front Cell Dev Biol"},{"key":"2380_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-022-00816-z","volume":"29","author":"K Wang","year":"2022","unstructured":"Wang K, Chen YF, Yang YSH et al (2022) The power of heteronemin in cancers. J Biomed Sci 29:41","journal-title":"J Biomed Sci"},{"key":"2380_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.711227","volume":"8","author":"LM Ruiz","year":"2021","unstructured":"Ruiz LM, Libedinsky A, Elorza AA (2021) Role of copper on mitochondrial function and metabolism. Front Mol Biosci 8:711227","journal-title":"Front Mol Biosci"},{"key":"2380_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2026.116519","volume":"178","author":"J Lakkakula","year":"2026","unstructured":"Lakkakula J, Kumar A, Singh N, Singh A, Uddin I (2026) Unveiling the therapeutic potential of copper nanoparticles for cancer treatment: a systematic review. Int Immunopharmacol 178:116519","journal-title":"Int Immunopharmacol"},{"key":"2380_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2026.109720","volume":"174","author":"J Ou","year":"2026","unstructured":"Ou J, Yang L, Zhang L, Jiang T, Qiao J, Pang M (2026) Copper-doped COF triggered bioorthogonal synergistic cancer therapy through apoptosis and cuproptosis. Bioorg Chem 174:109720","journal-title":"Bioorg Chem"},{"key":"2380_CR45","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s11033-026-11821-y","volume":"53","author":"P Thakur","year":"2026","unstructured":"Thakur P, Patel TN (2026) Crossroads of iron, copper, and zinc in cancer: a paradox of toxicity and therapy. Mol Biol Rep 53:634","journal-title":"Mol Biol Rep"},{"key":"2380_CR46","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.tips.2026.02.004","volume":"47","author":"W Qin","year":"2026","unstructured":"Qin W, Sheng H, Hu X, Burden RE, Martin SL, Wu H (2026) Cuproptosis in cancer: emerging mechanism and therapeutic opportunities. Trends Pharmacol Sci 47:386\u2013402","journal-title":"Trends Pharmacol Sci"},{"key":"2380_CR47","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1177\/10445498251403436","volume":"45","author":"Q Yang","year":"2026","unstructured":"Yang Q, Zhao Y, Zhu L et al (2026) Cuproptosis: revolutionizing cancer treatment with copper\u2019s hidden potential. DNA Cell Biol 45:50\u201359","journal-title":"DNA Cell Biol"},{"key":"2380_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.105066","volume":"218","author":"D Zhang","year":"2026","unstructured":"Zhang D, Zhao Y, Guo D (2026) Application and potential of the tumor microenvironment, ferroptosis, cuproptosis, and disulfidptosis in cancer treatment and monitoring. Crit Rev Oncol Hematol 218:105066","journal-title":"Crit Rev Oncol Hematol"},{"key":"2380_CR49","doi-asserted-by":"publisher","first-page":"7689045","DOI":"10.1155\/2021\/7689045","volume":"2021","author":"WT Chang","year":"2021","unstructured":"Chang WT, Bow YD, Fu PJ et al (2021) A Marine terpenoid, heteronemin, induces both the apoptosis and ferroptosis of hepatocellular carcinoma cells and involves the ROS and MAPK pathways. Oxid Med Cell Longev 2021:7689045","journal-title":"Oxid Med Cell Longev"},{"key":"2380_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2024.124145","volume":"352","author":"M Li","year":"2024","unstructured":"Li M, Tang S, Velkov T, Shen J, Dai C (2024) Copper exposure induces mitochondrial dysfunction and hepatotoxicity via the induction of oxidative stress and PERK\/ATF4 -mediated endoplasmic reticulum stress. Environ Pollut 352:124145","journal-title":"Environ Pollut"},{"key":"2380_CR51","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3390\/md16060212","volume":"16","author":"YC Chen","year":"2018","unstructured":"Chen YC, Lu MC, El-Shazly M et al (2018) Breaking down Leukemia Walls: heteronemin, a sesterterpene derivative, induces apoptosis in leukemia Molt4 cells through oxidative stress, mitochondrial dysfunction and induction of talin expression. Mar Drugs 16:212","journal-title":"Mar Drugs"},{"key":"2380_CR52","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3390\/md16060204","volume":"16","author":"MG Lee","year":"2018","unstructured":"Lee MG, Liu YC, Lee YL et al (2018) Heteronemin, a marine sesterterpenoid-type metabolite, induces apoptosis in prostate LNcap cells via oxidative and ER stress combined with the inhibition of topoisomerase II and Hsp90. Mar Drugs 16:204","journal-title":"Mar Drugs"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02380-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02380-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02380-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:02:37Z","timestamp":1784052157000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-026-02380-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2380"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02380-5","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"2 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"175"}}